The FMI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the FMI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The FMI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View FMI Detailed Price Forecast - CNN Money||View FMI Detailed Summary - Google Finance|
|View FMI Detailed Summary - Yahoo! Finance||View FMI Stock Research & Analysis - Zacks.com|
|View FMI Trends & Analysis - Trade-Ideas||View FMI Major Holders - Barrons|
|View FMI Call Transcripts - NASDAQ||View FMI Breaking News & Analysis - Seeking Alpha|
|View FMI Annual Report - CompanySpotlight.com||View FMI OTC Short Report - OTCShortReport.com|
|View FMI Fundamentals - TradeKing||View FMI SEC Filings - Bar Chart|
|View Historical Prices for FMI - The WSJ||View Performance/Total Return for FMI - Morningstar|
|View the Analyst Estimates for FMI - MarketWatch||View the Earnings History for FMI - CNBC|
|View the FMI Earnings - StockMarketWatch||View FMI Buy or Sell Recommendations - MacroAxis|
|View the FMI Bullish Patterns - American Bulls||View FMI Short Pain Metrics - ShortPainBot.com|
|View FMI Stock Mentions - StockTwits||View FMI Stock Mentions - PennyStockTweets|
|View FMI Stock Mentions - Twitter||View FMI Investment Forum News - Investor Hub|
|View FMI Stock Mentions - Yahoo! Message Board||View FMI Stock Mentions - Seeking Alpha|
|View Insider Transactions for FMI - SECform4.com||View Insider Transactions for FMI - Insider Cow|
|View FMI Major Holdings Summary - CNBC||View Insider Disclosure for FMI - OTC Markets|
|View Insider Transactions for FMI - Yahoo! Finance||View Institutional Holdings for FMI - NASDAQ|
|View FMI Stock Insight & Charts - FinViz.com||View FMI Investment Charts - StockCharts.com|
|View FMI Stock Overview & Charts - BarChart||View FMI User Generated Charts - Trading View|
With new blood test, Roche dives deeper into personal cancer care
Posted on Monday September 24, 2018
Swiss drugmaker Roche upped its bet on personalised cancer treatment on Monday, saying it is now ready to sell a blood test around the world that can identify common gene mutations from solid tumours from a patient's blood. The blood test, called FoundationOne Liquid, is among initial products to emerge from Foundation Medicine after Roche spent $2.4 billion on the U.S.-based genetic profiling company this year on the conviction that future cancer treatment will be tailored to individual characteristics of a patient's tumour.
Incyte, Foundation Medicine Partner for Companion Diagnostics
Posted on Wednesday September 12, 2018
Incyte (INCY) inks an agreement with Foundation Medicine for the development of companion diagnostics (CDx) for Incy's selective FGFR Inhibitor, pemigatinib.
Foundation Medicine, today announced the publication of the results of a large study demonstrating that its novel, investigational assay to measure blood tumor mutational burden (bTMB) can help predict response to the anti-PD-L1 immunotherapy, atezolizumab, (TECENTRIQ®) in patients with previously treated non-small cell lung cancer (NSCLC). The study, published in the journal Nature Medicine, was the result of a collaboration between Foundation Medicine and Genentech, a member of the Roche Group, and demonstrates the potential of bTMB to expand precision oncology approaches for patients with advanced cancers, including metastatic lung cancer. In addition, these results show that bTMB may be an independent predictor of clinical benefit, regardless of PD-L1 expression as assessed by immunohistochemistry.
Roche Purchases Shares in Tender Offer for FMI
Posted on Tuesday July 31, 2018
OTCQX: RHHBY) and Foundation Medicine, Inc. (FMI) today announced that Roche`s wholly owned subsidiary 062018 Merger Subsidiary, Inc. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of Foundation Medicine not already owned by Roche or its affiliates, at a price of $137.00 per share in cash. The tender offer expired at 12:00 midnight, Eastern Time, at the end of the day on 30 July 2018 and was not extended.